The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Characterization of the genomic alterations in poorly differentiated thyroid cancer

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer, World Journal of Surgical Oncology

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma

Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities. - Abstract - Europe PMC

Frontiers Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Frontiers LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study, BMC Pulmonary Medicine